GALECTIN THERAPEUTICS INC (GALT) Stock Balance Sheet
NASDAQ:GALT - Nasdaq - US3632252025 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 27.06M | 25.66M | 18.59M | 39.65M | 27.14M | |||
| Other Current Assets | 1.61M | 2.05M | 1.96M | 2.17M | 2.32M | |||
| Total Current Assets | 28.67M | 27.71M | 20.55M | 41.82M | 29.47M | |||
| Non-Current Assets | ||||||||
| PPE Net | 26.00K | 53.00K | 90.00K | 10.00K | 50.00K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 280.00K | 437.00K | 650.00K | N/A | 90.00K | |||
| Total Non-Current Assets | 306.00K | 490.00K | 740.00K | 10.00K | 130.00K | |||
| TOTAL ASSETS | 28.97M | 28.20M | 21.29M | 41.83M | 29.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 10.52M | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 11.59M | 9.18M | 9.06M | 7.16M | 4.04M | |||
| Accounts Payable | 2.79M | 6.43M | 3.89M | 1.81M | 1.29M | |||
| Other Current Liabilities | 359.00K | 63.00K | 60.00K | 70.00K | 70.00K | |||
| Total Current Liabilities | 25.26M | 15.68M | 13.01M | 9.03M | 5.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 94.04M | 71.74M | 39.83M | 29.05M | 0.00 | |||
| Other Non-Current Liabilities | 2.16M | 1.02M | 640.00K | 1.13M | 10.00K | |||
| Total Non-Current Liabilities | 96.19M | 72.77M | 40.47M | 30.18M | 10.00K | |||
| TOTAL LIABILITIES | 121.45M | 88.44M | 53.48M | 39.21M | 5.41M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -389.54M | -354.37M | -309.57M | -270.69M | -240.00M | |||
| Additional Paid In Capital | 294.78M | 291.85M | 275.08M | 271.00M | 261.88M | |||
| Common Shares | 2.28M | 2.28M | 2.29M | 2.31M | 2.31M | |||
| Shares Outstanding | 62.31M | 61.85M | 59.43M | 59.34M | 57.08M | |||
| Tangible Book Value per Share | -1.52 | -1.01 | -0.58 | 0.01 | 0.38 | |||
| Total Shareholders' Equity | -92.48M | -60.24M | -32.19M | 2.62M | 24.19M | |||
| TOTAL LIABILITIES AND EQUITY | 28.97M | 28.20M | 21.29M | 41.83M | 29.60M | |||
| Statistics | ||||||||
| Debt/Equity | -1.02 | -1.19 | -1.24 | 11.09 | N/A | |||
| Current Ratio | 1.13 | 1.77 | 1.58 | 4.63 | 5.46 | |||
| Return On Assets (ROA) | -156.12% | -158.88% | -182.57% | -73.39% | -79.73% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | -1171.76% | -97.56% | |||
All data in USD , ROIC based on taxRate of 0.21